Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 04-2022 | 01-2022 | 10-2021 | 07-2021 | 04-2021 | |
| Sales | 0 | 0 | -1 | 0 | 0 |
| Gross Profit | N/A | N/A | -1 | N/A | N/A |
| Operating Expenses | 3,589 | 3,880 | 4,077 | 4,388 | 2,437 |
| Operating Income | -3,589 | -3,880 | -4,078 | -4,388 | -2,437 |
| Other Income | 1 | 1 | 7 | 0 | 0 |
| Pre-tax Income | -3,588 | -3,879 | -4,071 | -4,388 | -2,437 |
| Net Income Continuous | -3,588 | -3,879 | -4,071 | -4,388 | -2,437 |
| Minority Interests | -44 | -50 | -58 | -54 | -38 |
| Net Income | $-3,544 | $-3,829 | $-4,013 | $-4,334 | $-2,399 |
| EPS Basic Total Ops | -0.12 | -0.13 | -0.14 | -0.14 | -0.08 |
| EPS Basic Continuous Ops | -0.12 | -0.13 | -0.14 | -0.14 | -0.09 |
| EPS Diluted Total Ops | -0.12 | -0.13 | -0.14 | -0.14 | -0.08 |
| EPS Diluted Continuous Ops | -0.12 | -0.13 | -0.14 | -0.14 | -0.09 |
| EBITDA(a) | $-3,578 | $-3,870 | $-4,062 | $-4,373 | $-2,422 |